Pharma Strategy Blog

Many studies are now being conducted to find lung cancer biomarkers in the blood. With advances in methods and technology, together with the considerable efforts to find early and novel diagnostic lung cancer biomarkers, new candidates will be discovered; leading to early diagnosis, detection, monitoring and efficient treatment of lung cancers.

Systematic review of the literature evaluating the predictors of death in patients with cirrhosis and HCC and to evaluate whether the predictors differ between patients with compensated and decompensated cirrhosis.

Researchers have discovered a way to identify drugs that can specifically attack and kill cancer stem cells, a finding that could lead to a new generation of anticancer medicines and a new strategy of treatment.